5,527 Shares in Encompass Health Corporation $EHC Acquired by Diversify Advisory Services LLC

Diversify Advisory Services LLC bought a new stake in Encompass Health Corporation (NYSE:EHC) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 5,527 shares of the company’s stock, valued at approximately $629,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of EHC. EP Wealth Advisors LLC raised its position in shares of Encompass Health by 2.4% during the 2nd quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock valued at $453,000 after buying an additional 88 shares in the last quarter. Gamco Investors INC. ET AL increased its stake in Encompass Health by 2.0% in the first quarter. Gamco Investors INC. ET AL now owns 4,813 shares of the company’s stock valued at $466,000 after acquiring an additional 94 shares during the last quarter. Gibson Capital LLC raised its position in Encompass Health by 4.3% during the first quarter. Gibson Capital LLC now owns 2,431 shares of the company’s stock valued at $235,000 after purchasing an additional 101 shares in the last quarter. Leuthold Group LLC lifted its stake in Encompass Health by 0.3% during the fourth quarter. Leuthold Group LLC now owns 31,168 shares of the company’s stock worth $3,308,000 after purchasing an additional 104 shares during the last quarter. Finally, Covestor Ltd lifted its stake in Encompass Health by 24.4% during the fourth quarter. Covestor Ltd now owns 540 shares of the company’s stock worth $57,000 after purchasing an additional 106 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Insider Buying and Selling

In other Encompass Health news, EVP John Patrick Darby sold 8,906 shares of the stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $125.95, for a total value of $1,121,710.70. Following the completion of the sale, the executive vice president owned 75,041 shares in the company, valued at approximately $9,451,413.95. This trade represents a 10.61% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Mark J. Tarr sold 173,148 shares of Encompass Health stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $125.47, for a total value of $21,724,879.56. Following the completion of the sale, the chief executive officer owned 267,814 shares in the company, valued at approximately $33,602,622.58. This represents a 39.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 1.80% of the company’s stock.

Encompass Health Trading Down 0.7%

Shares of EHC opened at $120.89 on Friday. The stock has a market capitalization of $11.93 billion, a P/E ratio of 19.69, a PEG ratio of 2.47 and a beta of 0.72. Encompass Health Corporation has a twelve month low of $92.77 and a twelve month high of $127.99. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.76. The firm has a fifty day simple moving average of $110.63 and a two-hundred day simple moving average of $106.29.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.48 by $0.07. The firm had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.57 billion. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.40 earnings per share. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. On average, research analysts anticipate that Encompass Health Corporation will post 6.08 EPS for the current year.

Encompass Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be issued a dividend of $0.21 per share. The ex-dividend date is Thursday, October 1st. This represents a $0.84 dividend on an annualized basis and a yield of 0.7%. This is a boost from Encompass Health’s previous quarterly dividend of $0.19. Encompass Health’s dividend payout ratio (DPR) is presently 12.38%.

Wall Street Analyst Weigh In

EHC has been the topic of several recent research reports. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, August 16th. Weiss Ratings upgraded Encompass Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, August 12th. Truist Financial upped their target price on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Barclays increased their price target on shares of Encompass Health from $140.00 to $144.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Finally, Leerink Partners set a $152.00 price objective on shares of Encompass Health in a report on Friday, May 22nd. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $148.71.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.